Kevin A. Henry

1.5k total citations
47 papers, 1.1k citations indexed

About

Kevin A. Henry is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Kevin A. Henry has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Radiology, Nuclear Medicine and Imaging, 27 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Kevin A. Henry's work include Monoclonal and Polyclonal Antibodies Research (31 papers), Glycosylation and Glycoproteins Research (19 papers) and Protein purification and stability (13 papers). Kevin A. Henry is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (31 papers), Glycosylation and Glycoproteins Research (19 papers) and Protein purification and stability (13 papers). Kevin A. Henry collaborates with scholars based in Canada, United States and United Kingdom. Kevin A. Henry's co-authors include C. Roger MacKenzie, Karen Pawlish, L Roche, Xiaoling Niu, Jamshid Tanha, Jamie K. Scott, Martín A. Rossotti, Greg Hussack, Mehdi Arbabi‐Ghahroudi and Kasandra Bélanger and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical Journal.

In The Last Decade

Kevin A. Henry

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin A. Henry Canada 18 528 486 292 213 155 47 1.1k
Angelika B. Riemer Germany 25 628 1.2× 960 2.0× 419 1.4× 968 4.5× 50 0.3× 57 2.0k
Josephine Kang United States 20 170 0.3× 313 0.6× 354 1.2× 223 1.0× 34 0.2× 36 1.5k
N. N. Teng United States 21 384 0.7× 560 1.2× 300 1.0× 497 2.3× 29 0.2× 37 2.1k
Paul Sims United States 10 213 0.4× 317 0.7× 105 0.4× 247 1.2× 34 0.2× 14 762
Bert C. Del Villano United States 13 223 0.4× 441 0.9× 363 1.2× 254 1.2× 43 0.3× 19 1.1k
Robert Pelley United States 25 204 0.4× 342 0.7× 716 2.5× 123 0.6× 46 0.3× 54 1.5k
Kyoung‐Ho Pyo South Korea 21 100 0.2× 418 0.9× 892 3.1× 395 1.9× 93 0.6× 61 1.6k
Jo Morrison United Kingdom 25 77 0.1× 487 1.0× 553 1.9× 261 1.2× 48 0.3× 89 2.1k
Šimun Anđelinović Croatia 14 111 0.2× 331 0.7× 206 0.7× 28 0.1× 87 0.6× 72 1.0k

Countries citing papers authored by Kevin A. Henry

Since Specialization
Citations

This map shows the geographic impact of Kevin A. Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Henry more than expected).

Fields of papers citing papers by Kevin A. Henry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin A. Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Henry. The network helps show where Kevin A. Henry may publish in the future.

Co-authorship network of co-authors of Kevin A. Henry

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. Henry. A scholar is included among the top collaborators of Kevin A. Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. Henry. Kevin A. Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Eric K., et al.. (2024). Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens. Applied Microbiology and Biotechnology. 108(1). 232–232. 4 indexed citations
2.
Lei, Eric K., David R. Goodlett, Thomas C. Caffrey, et al.. (2024). Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Molecular Cancer Therapeutics. 23(6). 836–853. 1 indexed citations
3.
Kim, Dae Young, Michael J. Lowden, Qingling Yang, et al.. (2023). Sequence tolerance of immunoglobulin variable domain framework regions to noncanonical intradomain disulfide linkages. Journal of Biological Chemistry. 299(11). 105278–105278. 3 indexed citations
4.
Lowden, Michael J., Eric K. Lei, Greg Hussack, & Kevin A. Henry. (2023). Applications of High-Throughput DNA Sequencing to Single-Domain Antibody Discovery and Engineering. Methods in molecular biology. 2702. 489–540. 2 indexed citations
5.
Henry, Kevin A., Toya Nath Baral, Greg Hussack, et al.. (2021). Biparatopic single-domain antibodies against Axl achieve ultra-high affinity through intramolecular engagement. Biochemical and Biophysical Research Communications. 562. 154–161. 8 indexed citations
6.
Faassen, Henk van, Frank St. Michael, Annie Aubry, et al.. (2020). Development and Characterization of Mouse Monoclonal Antibodies Specific for Clostridiodes (Clostridium) difficile Lipoteichoic Acid. ACS Chemical Biology. 15(4). 1050–1058. 7 indexed citations
7.
Henry, Kevin A., Greg Hussack, Michel Gilbert, et al.. (2019). Role of the non‐hypervariable FR3 D‐E loop in single‐domain antibody recognition of haptens and carbohydrates. Journal of Molecular Recognition. 32(11). e2805–e2805. 3 indexed citations
8.
Henry, Kevin A., Henk van Faassen, Doreen Harcus, et al.. (2019). Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct. Immunogenetics. 71(4). 307–320. 16 indexed citations
9.
Saberianfar, Reza, et al.. (2019). Plant-Produced Chimeric VHH-sIgA Against Enterohemorrhagic E. coli Intimin Shows Cross-Serotype Inhibition of Bacterial Adhesion to Epithelial Cells. Frontiers in Plant Science. 10. 270–270. 19 indexed citations
10.
Pon, Robert A., Martín A. Rossotti, Natalie Krahn, et al.. (2019). Modulating antibody‐dependent cellular cytotoxicity of epidermal growth factor receptor‐specific heavy‐chain antibodies through hinge engineering. Immunology and Cell Biology. 97(6). 526–537. 7 indexed citations
11.
Brooks, Cory L., Martín A. Rossotti, & Kevin A. Henry. (2018). Immunological Functions and Evolutionary Emergence of Heavy-Chain Antibodies. Trends in Immunology. 39(12). 956–960. 15 indexed citations
12.
Henry, Kevin A. & Jamshid Tanha. (2018). Performance evaluation of phage-displayed synthetic human single-domain antibody libraries: A retrospective analysis. Journal of Immunological Methods. 456. 81–86. 5 indexed citations
13.
Henry, Kevin A.. (2017). Next-Generation DNA Sequencing of VH/VL Repertoires: A Primer and Guide to Applications in Single-Domain Antibody Discovery. Methods in molecular biology. 1701. 425–446. 15 indexed citations
14.
Henry, Kevin A., Michael J. Lowden, Martín A. Rossotti, et al.. (2017). A disulfide-stabilized human V L single-domain antibody library is a source of soluble and highly thermostable binders. Molecular Immunology. 90. 190–196. 16 indexed citations
15.
Henry, Kevin A., Dae Young Kim, Michael J. Lowden, et al.. (2017). Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human VH/VL Single-Domain Antibodies from In Vitro Display Libraries. Frontiers in Immunology. 8. 1759–1759. 14 indexed citations
16.
Henry, Kevin A., Greg Hussack, Cathy Collins, et al.. (2016). Isolation of TGF-β-neutralizing single-domain antibodies of predetermined epitope specificity using next-generation DNA sequencing. Protein Engineering Design and Selection. 29(10). 439–443. 19 indexed citations
17.
Henry, Kevin A., Mehdi Arbabi‐Ghahroudi, & Jamie K. Scott. (2015). Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold. Frontiers in Microbiology. 6. 755–755. 72 indexed citations
18.
Alturki, Norah A., Kevin A. Henry, C. Roger MacKenzie, & Mehdi Arbabi‐Ghahroudi. (2015). Isolation of Camelid Single-Domain Antibodies Against Native Proteins Using Recombinant Multivalent Peptide Ligands. Methods in molecular biology. 1348. 167–189. 2 indexed citations
19.
Singh, Harvir, et al.. (2011). Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies. AIDS. 25(10). 1247–1257. 16 indexed citations
20.
Lindley, Roger, et al.. (1989). Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy.. PubMed. 105(1). 13–20. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026